New Owner
Merck & Co., Inc. - Cubist Pharmaceuticals
Merck & Co., Inc. acquires Cubist Pharmaceuticals
Announced: December 08, 2014
Type: Acquisition
Disposition: Separate Entity
Terms: Cash
Status: Complete
Amount: $ 8,400,000,000